West Pharmaceutical Services WST Cash Flow Statement (2009-2026)

NYSE WST
$390.02 +1.24 (+0.32%)
As of: Oct 21, 2026 · 10:08 AM EDT
Reported Financials

West Pharmaceutical Services Quarterly Cash Flow Statement

Periods 69 quarters
Latest Jun 2026

West Pharmaceutical Services reported cash from operations of $124.00M and free cash flow of $80.80M for the quarter ended Jun 2026, down 30.0% year over year. This cash flow statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
175.60M147.70M173.80M188.50M120.60M103.00M140.00M155.10M161.30M137.00M115.30M111.30M136.00M130.10M89.80M131.80M140.00M132.10M138.80M154.00M
Depreciation and DepletionDep. & Depletion
28.90M32.30M28.70M29.20M28.90M30.10M30.70M33.60M34.80M34.60M34.70M38.00M39.30M39.80M39.10M40.80M42.30M46.40M44.60M45.70M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
1.10M2.10M0.90M0.90M0.90M1.00M0.90M0.50M0.90M1.30M0.90M0.90M0.90M0.90M0.90M0.60M0.70M0.60M0.60M0.50M
Depreciation & Amortization (CF)Dep. & Amort.
28.90M32.30M28.70M29.20M28.90M30.10M30.70M33.60M34.80M34.60M34.70M38.00M39.30M39.80M39.10M40.80M42.30M46.40M44.60M45.70M
Share-based CompensationStock Comp.
11.30M10.00M5.50M5.50M6.00M6.70M8.50M7.50M5.90M1.40M5.00M4.30M5.10M4.30M1.30M7.40M8.40M6.70M6.60M10.90M
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
-9.40M-2.20M
Asset Writedowns and ImpairmentWritedown
0.20M1.40M4.60M1.90M1.50M3.50M2.70M0.60M0.30M1.00M5.40M0.30M3.80M0.30M7.30M0.30M3.90M
Cash from Restructuring
0.80M0.80M0.90M2.90M0.90M1.00M
Other non-cash itemsOther Non-Cash
-176.90M186.40M-7.50M-4.10M-6.30M15.90M-6.50M-5.90M-1.10M14.50M-3.70M-3.90M-2.10M5.00M-2.90M-4.00M2.50M-3.00M1.00M-6.00M
Change in Working Capital
24.80M-34.60M14.10M-0.10M0.10M-4.10M2.10M-102.90M-86.00M
Other Working Capital ChangesOther WC Changes
151.00M19.90M-50.20M-48.30M-32.20M185.40M-46.80M-25.30M24.80M53.30M-34.60M
Other Operating ActivitiesOther Ops.
-0.20M-0.40M-0.40M-0.40M-0.60M-0.60M
Cash from OperationsCash from Ops.
190.10M160.80M151.20M173.10M168.90M230.80M138.10M169.20M230.10M239.10M118.20M165.00M180.10M190.10M129.40M177.10M197.20M251.10M89.90M124.00M
Investing Activities
Capital ExpendituresCapex
65.30M76.50M65.80M66.10M57.80M94.90M82.10M75.40M95.80M108.70M90.60M100.20M81.30M104.90M71.30M75.20M63.30M76.10M42.70M43.20M
Change in Property, Plant and EquipmentChange in PP&E
-65.30M-76.50M-65.80M-66.10M-57.80M-94.90M-82.10M-75.40M-95.80M-108.70M-90.60M-100.20M-81.30M-104.90M-71.30M-75.20M-63.30M-76.10M-42.70M-43.20M
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Change in Acquisitions & DivestmentsChange Acquisitions
Other Investing ActivitiesOther investing
1.30M-2.50M0.10M-1.30M0.10M-6.70M0.10M-0.10M-0.80M0.10M
Cash from Investing ActivitiesCash from Investing
-65.30M-77.40M-68.30M-66.00M-59.10M-94.80M-82.10M-82.10M-95.70M-108.80M-90.60M-101.20M-82.10M-104.80M-71.30M-75.20M-63.30M-76.10M-42.70M-43.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
129.70M
Long-Term Debt RepaymentsLT Debt Repayment
1.10M0.60M0.50M42.60M0.60M0.60M0.60M0.70M0.70M22.90M133.20M0.10M0.20M0.30M0.30M0.30M0.30M50.40M
Non-Current Debt
-1.10M-0.60M-0.50M-42.60M-0.60M-0.60M-0.60M-0.70M-0.70M-22.90M-3.50M-0.10M-0.20M-0.30M-0.30M-0.30M-0.30M-50.40M
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-1.10M-0.60M-0.50M-42.60M-0.60M-0.60M-0.60M-0.70M-0.70M-22.90M-3.50M-0.10M-0.20M-0.30M-0.30M-0.30M-0.30M-50.40M
Change in Capital Stock
Common Stock IssuedStock Issued
7.10M8.30M8.30M6.50M8.40M5.00M15.30M12.20M20.40M3.10M16.80M6.80M6.00M3.10M4.40M5.20M4.00M4.60M7.50M8.80M
Shares Repurchased
147.10M28.60M27.20M-0.10M60.10M173.40M27.80M177.00M267.00M187.10M52.40M54.40M133.50M0.50M297.60M156.70M
Net Shares Issued and RepurchasedNet Shares Issued
7.10M8.30M-138.80M-22.10M-18.80M5.10M-44.80M-161.20M-7.40M-173.90M-250.20M-180.30M-46.40M-51.30M-129.10M4.70M4.00M4.60M-290.10M-147.90M
Net Equity Issued and RepurchasedNet Equity Issued
7.10M8.30M-138.80M-22.10M-18.80M5.10M-44.80M-161.20M-7.40M-173.90M-250.20M-180.30M-46.40M-51.30M-129.10M4.70M4.00M4.60M-290.10M-147.90M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
12.60M13.30M13.40M13.10M13.50M14.10M14.10M14.10M14.00M14.80M14.70M14.60M14.50M15.30M15.20M15.10M15.10M15.80M15.80M15.70M
Dividends Paid - Common and PrefferdDiv Paid (Total)
12.60M13.30M13.40M13.10M13.50M14.10M14.10M14.10M14.00M14.80M14.70M14.60M14.50M15.30M15.20M15.10M15.10M15.80M15.80M15.70M
Other financing activitiesOther financing
-0.30M-0.10M-19.90M-0.50M-0.30M0.10M-11.50M-1.00M-0.30M-0.10M-5.40M-0.10M-2.20M-2.50M-4.20M-0.10M-0.20M-2.50M-0.80M
Cash from Financing ActivitiesCash from Financing
-5.80M-6.20M-172.70M-36.20M-75.20M-9.50M-71.00M-176.80M-22.30M-189.50M-271.00M-218.30M-64.40M-68.90M-147.00M-14.90M-11.50M-11.70M-308.70M-164.80M
Additional items
Exchange Rate EffectFX Effect
-7.20M-2.60M-5.10M-20.10M-24.10M38.80M7.00M-0.30M-9.80M14.50M-8.70M-1.10M11.10M-22.70M8.50M18.50M-3.60M-0.50M-8.40M-1.60M
Change in Cash
111.80M74.60M-94.90M50.80M10.50M165.30M-8.00M-90.00M102.30M-44.70M-252.10M-155.60M44.70M-6.30M-80.40M105.50M118.80M162.80M-269.90M-85.60M
Ending Cash Balance
688.00M762.60M667.70M718.50M729.00M894.30M886.30M796.30M898.60M853.90M601.80M446.20M490.90M484.60M404.20M509.70M628.50M791.30M521.40M435.80M
Free Cash FlowFCF
124.80M84.30M85.40M107.00M111.10M135.90M56.00M93.80M134.30M130.40M27.60M64.80M98.80M85.20M58.10M101.90M133.90M175.00M47.20M80.80M
Net Cash FlowNCF
119.00M77.20M-89.80M70.90M34.60M126.50M-15.00M-89.70M112.10M-59.20M-243.40M-154.50M33.60M16.40M-88.90M87.00M122.40M163.30M-261.50M-84.00M

West Pharmaceutical Services Cash Flow Statement API

Pull West Pharmaceutical Services's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=WST&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY